Evidence map›Paper›PMID 25274297›Full record

ArticleNature2014

Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness.

Joseph M Pickard, Corinne F Maurice, Melissa A Kinnebrew, Michael C Abt, Dominik Schenten, Tatyana V Golovkina, Said R Bogatyrev, Rustem F Ismagilov, Eric G Pamer, Peter J Turnbaugh and 1 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 309 papers.

0numbers the graph read from it
0cells of the map it votes in
309citing papers in PubMed
24.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

309 citing papers in PubMed, 504 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

249 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Joseph M PickardDepartment of Pathology and Committee on Immunology, The University of Chicago, Chicago, Illinois 60637, USA.
Corinne F MauriceFAS Center for Systems Biology, Harvard University, Cambridge, Massachusetts 02138, USA.
Melissa A KinnebrewMemorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Michael C AbtMemorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Dominik SchentenThe University of Arizona, Tucson, Arizona 85721, USA.
Tatyana V GolovkinaDepartment of Microbiology, The University of Chicago, Chicago, Illinois 60637, USA.
Said R BogatyrevCalifornia Institute of Technology, Pasadena, California 91125, USA.
Rustem F IsmagilovCalifornia Institute of Technology, Pasadena, California 91125, USA.
Eric G PamerMemorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Peter J TurnbaughFAS Center for Systems Biology, Harvard University, Cambridge, Massachusetts 02138, USA.
Alexander V ChervonskyDepartment of Pathology and Committee on Immunology, The University of Chicago, Chicago, Illinois 60637, USA.
Memorial Sloan Kettering Cancer Center · USCalifornia Institute of Technology · USHarvard University · USUniversity of Arizona · USUniversity of Chicago · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI LIU, CAMBRIAN YANGSHAO · 1990 to 2025
$29.8M
THEORETICAL ANALYSIS OF FUNCTIONAL MODULESP50GM068763 · NIGMS · HARVARD UNIVERSITY · PI BENENSON, YAAKOV · 2003 to 2012
$28.9M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007090 · NIAID · UNIVERSITY OF CHICAGO · PI Peter Aidan Savage · 1985 to 2026
$11.7M
TNF Mediated Immune Defense Against Listeria InfectionR01AI042135 · NIAID · YALE UNIVERSITY · PI PAMER, ERIC G. · 1998 to 2019
$7.3M
Innate Immune Defense against Clostridium Difficile InfectionR01AI095706 · NIAID · UNIVERSITY OF CHICAGO · PI PAMER, ERIC G. · 2012 to 2020
$3.4M
Retroviral Evasion of Immune ResponseR01AI090084 · NIAID · UNIVERSITY OF CHICAGO · PI GOLOVKINA, TATYANA V · 2012 to 2016
$2.1M
Biodefense Training in Host-Pathogen InteractionsT32AI065382 · NIAID · UNIVERSITY OF CHICAGO · PI SCHNEEWIND, OLAF · 2005 to 2009
$688k
A novel vaccine against vaginal Chlamydia trachomatisR41AI096706 · NIAID · EPITOGENESIS, INC. · PI DEAN, DEBORAH ANNE, VAJDY, MICHAEL SEJR · 2012 to 2013
$600k
NCATS NIH HHS UL1 TR000430NCI NIH HHS P30 CA008748NIAID NIH HHS AI42135NIAID NIH HHS AI96706NIAID NIH HHS R01 AI042135NIAID NIH HHS R01 AI090084NIAID NIH HHS R01 AI095706NIAID NIH HHS R41 AI096706NIAID NIH HHS T32 AI007090NIAID NIH HHS T32 AI065382NIDDK NIH HHS DK42086NIDDK NIH HHS P30 DK042086NIGMS NIH HHS P50 GM068763NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

Systemic infection induces conserved physiological responses that include both resistance and 'tolerance of infection' mechanisms. Temporary anorexia associated with an infection is often beneficial, reallocating energy from food foraging towards resistance to infection or depriving pathogens of nutrients. However, it imposes a stress on intestinal commensals, as they also experience reduced substrate availability; this affects host fitness owing to the loss of caloric intake and colonization resistance (protection from additional infections). We hypothesized that the host might utilize internal resources to support the gut microbiota during the acute phase of the disease. Here we show that systemic exposure to Toll-like receptor (TLR) ligands causes rapid α(1,2)-fucosylation of small intestine epithelial cells (IECs) in mice, which requires the sensing of TLR agonists, as well as the production of interleukin (IL)-23 by dendritic cells, activation of innate lymphoid cells and expression of fucosyltransferase 2 (Fut2) by IL-22-stimulated IECs. Fucosylated proteins are shed into the lumen and fucose is liberated and metabolized by the gut microbiota, as shown by reporter bacteria and community-wide analysis of microbial gene expression. Fucose affects the expression of microbial metabolic pathways and reduces the expression of bacterial virulence genes. It also improves host tolerance of the mild pathogen Citrobacter rodentium. Thus, rapid IEC fucosylation appears to be a protective mechanism that utilizes the host's resources to maintain host-microbial interactions during pathogen-induced stress.

Indexed as

DiseaseSymbiosisAnimalsAnorexiaBacteriaCitrobacter rodentiumDendritic CellsEatingEpitheliumFatty AcidsFemaleFucoseFucosyltransferasesGalactoside 2-alpha-L-fucosyltransferaseGene Expression Regulation, BacterialGlycosylationFatty AcidsFucoseFucosyltransferasesGalactoside 2-alpha-L-fucosyltransferaseInterleukin-22InterleukinsLigandsToll-Like ReceptorsVirulence Factors

Identifiers

PMID25274297
PMCPMC4214913
OpenAlexW1965301687

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.